Species differences in the deamination of dopamine and other substrates for monoamine oxidase in brain.
D000818:Animals; D001921:Brain / Q000201:enzymology*; D002421:Caudate Nucleus / Q000201:enzymology; D002540:Cerebral Cortex / Q000201:enzymology; D002522:Chlorocebus aethiops; D003010:Clorgyline / Q000494:pharmacology; D003641:Deamination; D004298:Dopamine / Q000378:metabolism*; D005260:Female; D006801:Humans; D008253:Macaca mulatta; D008297:Male; D008995:Monoamine Oxidase / Q000378:metabolism*; D008996:Monoamine Oxidase Inhibitors / Q000494:pharmacology; D010293:Pargyline / Q000494:pharmacology; D010627:Phenethylamines / Q000378:metabolism; D051381:Rats; D012642:Selegiline / Q000494:pharmacology; D012701:Serotonin / Q000378:metabolism; D013045:Species Specificity; D013379:Substrate Specificity; D014439:Tyramine / Q000378:metabolism
D008996:Monoamine Oxidase Inhibitors; D010627:Phenethylamines; D012642:Selegiline; D012701:Serotonin; D010293:Pargyline; D008995:Monoamine Oxidase; D003010:Clorgyline; D004298:Dopamine; D014439:Tyramine